These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 37337213

  • 1. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH, Nguyen NTT, Le DDT, Anwar MA, Lee SY.
    Cell Commun Signal; 2023 Jun 19; 21(1):149. PubMed ID: 37337213
    [Abstract] [Full Text] [Related]

  • 2. PIP5Kγ Mediates PI(4,5)P2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo-YAP Pathway Regulation.
    Le DDT, Le TPH, Lee SY.
    Int J Mol Sci; 2023 Sep 30; 24(19):. PubMed ID: 37834234
    [Abstract] [Full Text] [Related]

  • 3. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
    Sabra H, Brunner M, Mandati V, Wehrle-Haller B, Lallemand D, Ribba AS, Chevalier G, Guardiola P, Block MR, Bouvard D.
    J Biol Chem; 2017 Nov 24; 292(47):19179-19197. PubMed ID: 28972170
    [Abstract] [Full Text] [Related]

  • 4. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL.
    Genes Dev; 2015 Jun 15; 29(12):1271-84. PubMed ID: 26109050
    [Abstract] [Full Text] [Related]

  • 5. Conformational flexibility determines the Nf2/merlin tumor suppressor functions.
    Primi MC, Rangarajan ES, Patil DN, Izard T.
    Matrix Biol Plus; 2021 Dec 15; 12():100074. PubMed ID: 34337379
    [Abstract] [Full Text] [Related]

  • 6. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
    Thines L, Gorisse L, Li Z, Sayedyahossein S, Sacks DB.
    J Biol Chem; 2022 May 15; 298(5):101839. PubMed ID: 35307353
    [Abstract] [Full Text] [Related]

  • 7. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
    Gu Y, Wang Y, Sha Z, He C, Zhu Y, Li J, Yu A, Zhong Z, Wang X, Sun Y, Lan F, Yu FX.
    Cell Rep; 2022 Aug 30; 40(9):111296. PubMed ID: 36044856
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
    Park J, Kim JS, Nahm JH, Kim SK, Lee DH, Lim DS.
    Mol Cells; 2020 May 31; 43(5):491-499. PubMed ID: 32451369
    [Abstract] [Full Text] [Related]

  • 10. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S, McCollum D.
    J Biol Chem; 2018 Nov 23; 293(47):18230-18241. PubMed ID: 30266805
    [Abstract] [Full Text] [Related]

  • 11. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
    Zheng M, Li RG, Song J, Zhao X, Tang L, Erhardt S, Chen W, Nguyen BH, Li X, Li M, Wang J, Evans SM, Christoffels VM, Li N, Wang J.
    Circulation; 2022 Nov 29; 146(22):1694-1711. PubMed ID: 36317529
    [Abstract] [Full Text] [Related]

  • 12. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation.
    Wu Y, Qin K, Xu Y, Rajhans S, Vo T, Lopez KM, Liu J, Nipper MH, Deng J, Yin X, Ramjit LR, Ye Z, Luan Y, Arda HE, Wang P.
    Elife; 2024 Jul 25; 13():. PubMed ID: 39051998
    [Abstract] [Full Text] [Related]

  • 13. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
    Li W, Cooper J, Zhou L, Yang C, Erdjument-Bromage H, Zagzag D, Snuderl M, Ladanyi M, Hanemann CO, Zhou P, Karajannis MA, Giancotti FG.
    Cancer Cell; 2014 Jul 14; 26(1):48-60. PubMed ID: 25026211
    [Abstract] [Full Text] [Related]

  • 14. Hippo pathway inactivation through subcellular localization of NF2/merlin in outer cells of mouse embryos.
    Goda N, Ito Y, Saito S, Suzuki M, Bai H, Takahashi M, Wakai T, Kawahara M.
    Development; 2024 Jul 15; 151(14):. PubMed ID: 39077779
    [Abstract] [Full Text] [Related]

  • 15. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C, Srivastava RK, Elmets CA, Afaq F, Athar M.
    Biochem Biophys Res Commun; 2013 Sep 06; 438(4):607-12. PubMed ID: 23942117
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW, Kim MK, Bae SC.
    Small GTPases; 2020 Jul 06; 11(4):280-288. PubMed ID: 29457552
    [Abstract] [Full Text] [Related]

  • 17. The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner.
    Ikeuchi M, Yuki R, Saito Y, Nakayama Y.
    FASEB J; 2021 Jan 06; 35(1):e21242. PubMed ID: 33368671
    [Abstract] [Full Text] [Related]

  • 18. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
    Wang Y, Cao W, Cui J, Yu Y, Zhao Y, Shi J, Wu J, Xia Z, Yu B, Liu J.
    Cell Physiol Biochem; 2018 Jan 06; 51(2):842-853. PubMed ID: 30466081
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.
    Serrano I, McDonald PC, Lock F, Muller WJ, Dedhar S.
    Nat Commun; 2013 Jan 06; 4():2976. PubMed ID: 24356468
    [Abstract] [Full Text] [Related]

  • 20. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S, Zhu Y, Liu X, Li P, Wang Y, Zeng Y, Yu A, Wang Y, Sha Z, Zhong Z, Zhu R, Yuan H, Ye D, Huang S, Ling C, Xu Y, Zhou D, Zhang L, Yu FX.
    Mol Cell; 2022 May 19; 82(10):1850-1864.e7. PubMed ID: 35429439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.